This revealed that among patients with AML without and with mutation, increased cutoff values resulted in a high percentage of CLB-positive cases compared to other AML subtypes (for ≥10%: Chi-square test, p = 0.01; for ≥15%: Chi-square test, p = 0.007). The gene discussed is CLYBL; the disease is acute myeloid leukemia.